Medizin
Refine
Year of publication
- 2009 (269) (remove)
Document Type
- Doctoral Thesis (143)
- Article (95)
- Part of Periodical (15)
- Conference Proceeding (11)
- Book (2)
- Review (2)
- Working Paper (1)
Has Fulltext
- yes (269)
Is part of the Bibliography
- no (269)
Keywords
- Bronchialasthma (2)
- Brustkrebs (2)
- HIV (2)
- Lungenfunktion (2)
- Sepsis (2)
- ADAM10 (1)
- Adipositas Chirurgie (1)
- Adoptivkind (1)
- Allergie (1)
- Allgemeinmedizin (1)
- Alzheimer's disease (1)
- Aminosäuremetabolismus (1)
- Aminosäuren (1)
- Antigen CD62 (1)
- Arbeit (1)
- Arbeitsmedizin (1)
- Asthma (1)
- Asthmadiagnostik (1)
- Atemtest (1)
- Autistic disorder (1)
- Baby-Bodyplethysmographie (1)
- Bacterial intestinal overgrowth (1)
- Basel Consensus Statement (1)
- Basler Consensus Statement (1)
- Behandlungssystematik (1)
- Behandlungsumfang (1)
- Berufskrankheit (1)
- Biglycan (1)
- Bodyplethysmographie (1)
- Bologna process (1)
- Bologna-Prozess (1)
- Brain tumor (1)
- Breath testing (1)
- Bronchial challenge (1)
- Bronchiale Hyperreagibilität (1)
- Bundesärztekammer / Ausschuss Arbeitsmedizin (1)
- CD62 (1)
- CPET (1)
- CXCL16 (1)
- Children (1)
- Chronische Krankheit (1)
- Comorbidities (1)
- Complex Systems (1)
- Copy number variation (1)
- Cox-2-Inhibitoren (1)
- Cox-Regression (1)
- Cyclooxygenase (1)
- Cystic fibrosis (1)
- Decorin (1)
- Depression (1)
- Deutsche Gesellschaft für Arbeitsmedizin (1)
- Deutschland (1)
- Diagnostics (1)
- Diagnostik (1)
- Didaktik (1)
- Dipeptide (1)
- Doppler-Sonographie (1)
- Down's syndrome (1)
- EFP1 (1)
- ER stress (1)
- Endotoxikose (1)
- Endotoxin (1)
- Erwachsener (1)
- Explorative Data Analysis (1)
- Explorative Datenanalyse (1)
- Fibrosis (1)
- Freiburg im Breisgau <2009> (1)
- Frühgeborenes (1)
- Gender (1)
- Geschlecht (1)
- Gesundheit (1)
- Glucose (1)
- Glukose (1)
- Gonarthrose (1)
- HBV (1)
- HCV (1)
- HIV-Infektion (1)
- Heben (1)
- Heme-Oxygenase 1 (1)
- Hepatitis (1)
- Herzinfarkt (1)
- Hypertension (1)
- Hypertonie (1)
- Häm-Oxygenase 1 (1)
- Immunchemie (1)
- Immunität <Medizin> (1)
- Immunologie (1)
- Immunsuppression (1)
- Immunsystem (1)
- Infektiologie (1)
- Infektion (1)
- Inflammation (1)
- Innate immunity (1)
- Intestinale bakterielle Fehlbesiedelung (1)
- Kaplan-Meier-Schätzung (1)
- Kardiomyopathie (1)
- Kardiovaskuläre Krankheit (1)
- Kindheit (1)
- Kleinkind (1)
- Kniegelenkarthrose (1)
- Kombinationstherapie (1)
- Kombinationstherapien (1)
- Komorbiditäten (1)
- Kongress (1)
- Krankenhausfinanzierung (1)
- L1 cell-adhesion molecule (L1-CAM) (1)
- Laparscopic Bariatric Surgery (1)
- Leber (1)
- Leukozyt (1)
- Linkage (1)
- Longitudinal Study (1)
- Longitudinalstudie (1)
- Low birth weight infant (1)
- Lumican (1)
- Lymphozyt (1)
- Medizinische Ausbildung (1)
- Metastase (1)
- Methacholinprovokation (1)
- Methionine (1)
- Microglia (1)
- Mitochondria (1)
- Modell-Curriculum (1)
- Molecular imaging (1)
- Monitoring (1)
- Mukoviszidose (1)
- Multivariate Analyse (1)
- Mutation (1)
- Myokardinfarkt (1)
- Nephrogenese (1)
- Neugeborenes (1)
- Nierentransplantation (1)
- Obstruktive Bronchitis (1)
- Oxidative stress (1)
- PAC-1 (1)
- PC20 (1)
- PD20 (1)
- PDI (1)
- PET (1)
- PINK1 (1)
- Par-4 (1)
- Parkin (1)
- Parkinson’s disease (1)
- Persönlichkeitsfaktor (1)
- Plättchenaktivierung (1)
- Primary care (1)
- Prädiktor (1)
- Präkonditionierung (1)
- Prüfung (1)
- Psychometrie (1)
- Reform (1)
- Renin-Angiotensin-Aldosteron-System (1)
- Resistenz (1)
- Sexualität (1)
- Spiroergometrie (1)
- Stammzelle (1)
- Stammzelltherapie (1)
- Suicidality (1)
- Suizidalität (1)
- Therapy (1)
- Thrombozytenaggregation (1)
- Thrombozytenaktivierung (1)
- Tragen (1)
- Ultraschallkontrastmittel (1)
- Univariate Analyse (1)
- Unspezifische Provokation (1)
- Wheezy infants (1)
- Whole genome association (1)
- Wissenschaftsgeschichte (1)
- Xylose (1)
- Zahnmedizin (1)
- Zahnärztliche Behandlung (1)
- a disintegrin and metalloprotease 10 (ADAM10) (1)
- acute myocardial infarction (1)
- aggression (1)
- aging (1)
- airway obstruction (1)
- amino acids (1)
- analgesics (1)
- apoptosis (1)
- asthma (1)
- augmentation materials (1)
- baby-bodyplethysmography (1)
- back pain (1)
- behavioral performance (1)
- biocompatibility (1)
- brain imaging (1)
- branched-chain amino acids (BCAA) (1)
- breast cancer cells (1)
- bronchial hyperresponsiveness (1)
- cardiovascular event (1)
- cerebral autoregulation (1)
- cerebrale Autoregulation (1)
- childhood (1)
- coauthor ship (1)
- cognition (1)
- combination therapies (1)
- communication/social competencies (1)
- computational neuroscience (1)
- conduct disorder (1)
- cortex (1)
- cox-2-inhibitors (1)
- cyclooxygenases (1)
- dementia (1)
- diabetic nephropathy (1)
- didactic (1)
- dipeptide (1)
- doppler-sonography (1)
- endocarditis (1)
- endotheliale Progenitorzellen (1)
- endotoxin (1)
- exercise (1)
- extracellular matrix (1)
- fMRI (1)
- facial prosthesis (1)
- gamma (1)
- h-index (1)
- heavy (1)
- impact factor (1)
- implanto-prosthetic therapy (1)
- intervertebral disc (1)
- intravital microscopy (1)
- ischämische (1)
- knee (1)
- kommunikative/soziale Kompetenzen (1)
- lifting (1)
- liver (1)
- local field potential (1)
- low birth weight infant (1)
- medizinische Ausbildung (1)
- metastatic breast cancer (1)
- methacholine (1)
- microcirculation (1)
- mino acid metabolism (first pass) (1)
- model curriculum (1)
- monitoring (1)
- multivariate analysis (1)
- myocarditis (1)
- neonatal septic shock (1)
- nephrogenesis (1)
- neuropathic pain (1)
- newborn infant (1)
- nonlinear dynamics (1)
- nuclear translocation (1)
- obstruktive Bronchitiden (1)
- occupation (1)
- oscillations (1)
- osteoarthritis (1)
- overall survival (1)
- pericarditis (1)
- platelet activation (1)
- podocytes (1)
- polymorphism (1)
- pre-conditioning (1)
- predictor (1)
- prefrontal cortex (1)
- premature infant (1)
- presenilin (PS)/gamma-secretase activity (1)
- primary tubular cells (1)
- protein C (1)
- psychiatry (1)
- quantum biology (1)
- renin-angiotensin-aldosterone-system (1)
- routine care (1)
- scientometrics (1)
- self-citation (1)
- sepsis (1)
- stem cell therapy (1)
- stimulus coding (1)
- survival analysis (1)
- synchrony (1)
- systemical treatment (1)
- testing (1)
- thioredoxin (1)
- transcranial (1)
- transcraniell (1)
- treatment scale (1)
- triple-negativen Mammakarzinomzellen (1)
- ultrasound contrast agent (1)
- undergraduate medical education (1)
- univariate analysis (1)
- verzweigtkettige Aminosäuren (1)
- violence (1)
- visual short-term memory (1)
- Überleben (1)
- Überlebenszeitanalyse (1)
Institute
The purpose of this study consists of the identification of implantologic and prosthetic methods and techniques used in substance loss rehabilitation, associated with identifying the specific biomaterials in perfect accordance with each case particularities, without leaving aside the bone-tissue deficiency etiology. A representative number of clinical cases were selected, cases which are relevant for the chosen theme. The possibility of reconstructing the natural parameters of the edentulous alveolar ridge areas is various, starting with augmentation materials of the autogenous and heterograft type biomaterials(Bio-Oss, Grafton, Cerasorb si MBCP) including the mixing of these two types of biomaterials, and going to epitheses, which are the best choise for complex substance loss.
Wer sich an das gremiensichere Deutsch wissenschaftlicher Antrags- und Aufsatzprosa gewöhnt hat (oder gewöhnen musste), wundert sich. Der emeritierte Professor der Sexualwissenschaft Volkmar Sigusch stellt die Geschichte der Sexualwissenschaft in einer Weise dar, die von den einen sicherlich vorschnell als diskursives Relikt der 68er abgetan, von den anderen als wohltuende Erinnerung an die Möglichkeit kritischer Wissenschaft angenommen werden wird. Ob "mannfrau" darüber verärgert oder erleichtert ist, sei dem/der Einzelnen überlassen. In jedem Fall gehen persönliches Engagement und überragendes Fachwissen, subjektive Einsichtnahme und Materialsättigung, Verständnis für die Akteure der Sexualwissenschaften und kritische Distanzierung, Eloge und Demystifikation in diesem Werk eine anregende Verbindung ein. Siguschs subjektive Objektivität kann als Beispiel und Kennzeichen kritischer Sexualwissenschaft gelten (S. 510). Sie macht aus der Lektüre des umfangreichen Buchs eine aufrüttelnde Erfahrung. Denn sie zwingt dazu, den gegenwärtigen (und nicht allein wissenschaftlichen) Umgang mit der körperlichen Liebe aus den Versprechungen, Verdrängungen und Verfehlungen der mit ihrer Erforschung betrauten Wissenschaft neu verstehen zu lernen. Insofern ist die Geschichte der Sexualwissenschaft ein sozial- und sittengeschichtliches Unternehmen ersten Ranges und von höchster Aktualität. ...
Elevated tumor interstitial fluid pressure (TIFP) is a characteristic of most solid tumors. Clinically, TIFP may hamper the uptake of chemotherapeutic drugs into the tumor tissue reducing their therapeutic efficacy. In this study, a means of modulating TIFP to increase the flux of macromolecules into tumor tissue is presented, which is based on the rationale that elevated plasma colloid osmotic pressure (COP) pulls water from tumor interstitium lowering the TIFP. Concentrated human serum albumin: (20% HSA), used as an agent to enhance COP, reduced the TIFP time-dependently from 8 to 2 mm Hg in human tumor xenograft models bearing A431 epidermoid vulva carcinomas. To evaluate whether this reduction facilitates the uptake of macromolecules, the intratumoral distribution of fluorescently conjugated dextrans (2.5 mg/ml) and cetuximab (2.0 mg/ml) was probed using novel time domain nearinfrared fluorescence imaging. This method permitted discrimination and semiquantification of tumor-accumulated conjugate from background and unspecific probe fluorescence. The coadministration of 20% HSA together with either dextrans or cetuximab was found to lower the TIFP significantly and increase the concentration of the substances within the tumor tissue in comparison to control tumors. Furthermore, combined administration of 20%HSA plus cetuximab reduced the tumor growth significantly in comparison to standard cetuximab treatment. These data demonstrate that increased COP lowers the TIFP within hours and increases the uptake of therapeutic macromolecules into the tumor interstitium leading to reduced tumor growth. This model represents a novel approach to facilitate the delivery of therapeutics into tumor tissue, particularly monoclonal antibodies.
Mitochondrial dysfunction is well documented in presymptomatic brain tissue with Parkinson's disease (PD). Identification of the autosomal recessive variant PARK6 caused by loss-of-function mutations in the mitochondrial kinase PINK1 provides an opportunity to dissect pathogenesis. Although PARK6 shows clinical differences to PD, the induction of alpha-synuclein "Lewy" pathology by PINK1-deficiency proves that mitochondrial pathomechanisms are relevant for old-age PD. Mitochondrial dysfunction is induced by PINK1 deficiency even in peripheral tissues unaffected by disease, consistent with the ubiquitous expression of PINK1. It remains unclear whether this dysfunction is due to PINK1-mediated phosphorylation of proteins inside or outside mitochondria. Although PINK1 deficiency affects the mitochondrial fission/fusion balance, cell stress is required in mammals to alter mitochondrial dynamics and provoke apoptosis. Clearance of damaged mitochondria depends on pathways including PINK1 and Parkin and is critical for postmitotic neurons with high energy demand and cumulative stress, providing a mechanistic concept for the tissue specificity of disease.
In the last decade, several sophisticated and accurate imaging methods such as positron emission tomography have been developed in order to evaluate malignant potential in enlarged mediastinal lymph nodes. This case illustrates an unusual presentation of sarcoidosis that mimicked lymphatic metastases of non small cell lung carcinoma. The reported high specificity and sensitivity of positron emission tomography-Computer Tomography regarding mediastinal staging could lead in same cases of false positives to a delaying of stage adapted therapy of non small cell lung carcinoma, showing that despite the recent advances of imaging techniques, such as positron emission tomography-computer tomography, several limitations of this imaging technique are still existing.
The human immunodeficiency virus (HIV) had spread unrecognized in the human population as sexually transmitted disease and was finally identified by its disease AIDS in 1981. Even after the isolation of the causative agent in 1983, the burden and death rate of AIDS accelerated worldwide especially in young people despite the confection of new drugs capable to inhibit virus replication since 1997. However, at least in industrialised countries, this trend could be reversed by the introduction of combination therapy strategies. The design of new drugs is on going; besides the inhibition of the three enzymes of HIV for replication and maturation (reverse transcriptase, integrase and protease), further drugs inhibits fusion of viral and cellular membranes and virus maturation. On the other hand, viral diagnostics had been considerably improved since the emergence of HIV. There was a need to identify infected people correctly, to follow up the course of immune reconstitution of patients by measuring viral load and CD4 cells, and to analyse drug escape mutations leading to drug resistance. Both the development of drugs and the refined diagnostics have been transferred to the treatment of patients infected with hepatitis B virus (HBV) and hepatitis C virus (HCV). This progress is not completed; there are beneficial aspects in the response of the scientific community to the HIV burden for the management of other viral diseases. These aspects are described in this contribution. Further aspects as handling a stigmatising disease, education of self-responsiveness within sexual relationships, and ways for confection of a protective vaccine are not covered.
Diabetic nephropathy (DN) is a major cause of end-stage renal failure worldwide. Oxidative stress has been reported to be a major culprit of the disease and increased oxidized low density lipoprotein (oxLDL) immune complexes were found in patients with DN. In this study we present evidence, that CXCL16 is the main receptor in human podocytes mediating the uptake of oxLDL. In contrast, in primary tubular cells CD36 was mainly involved in the uptake of oxLDL. We further demonstrate that oxLDL down-regulated α3-integrin expression and increased the production of fibronectin in human podocytes. In addition, oxLDL uptake induced the production of reactive oxygen species (ROS) in human podocytes. Inhibition of oxLDL uptake by CXCL16 blocking antibodies abrogated the fibronectin and ROS production and restored α3 integrin expression in human podocytes. Furthermore we present evidence that hyperglycaemic conditions increased CXCL16 and reduced ADAM10 expression in podocytes. Importantly, in streptozotocin-induced diabetic mice an early induction of CXCL16 was accompanied by higher levels of oxLDL. Finally immunofluorescence analysis in biopsies of patients with DN revealed increased glomerular CXCL16 expression, which was paralleled by high levels of oxLDL. In summary, regulation of CXCL16, ADAM10 and oxLDL expression may be an early event in the onset of DN and therefore all three proteins may represent potential new targets for diagnosis and therapeutic intervention in DN.
The manifestation of chronic back pain depends on structural, psychosocial, occupational and genetic influences. Heritability estimates for back pain range from 30% to 45%. Genetic influences are caused by genes affecting intervertebral disc degeneration or the immune response and genes involved in pain perception, signalling and psychological processing. This inter-individual variability which is partly due to genetic differences would require an individualized pain management to prevent the transition from acute to chronic back pain or improve the outcome. The genetic profile may help to define patients at high risk for chronic pain. We summarize genetic factors that (i) impact on intervertebral disc stability, namely Collagen IX, COL9A3, COL11A1, COL11A2, COL1A1, aggrecan (AGAN), cartilage intermediate layer protein, vitamin D receptor, metalloproteinsase-3 (MMP3), MMP9, and thrombospondin-2, (ii) modify inflammation, namely interleukin-1 (IL-1) locus genes and IL-6 and (iii) and pain signalling namely guanine triphosphate (GTP) cyclohydrolase 1, catechol-O-methyltransferase, μ opioid receptor (OPMR1), melanocortin 1 receptor (MC1R), transient receptor potential channel A1 and fatty acid amide hydrolase and analgesic drug metabolism (cytochrome P450 [CYP]2D6, CYP2C9).
Protein catabolism should be reduced and protein synthesis promoted with parenteral nutrion (PN). Amino acid (AA) solutions should always be infused with PN. Standard AA solutions are generally used, whereas specially adapted AA solutions may be required in certain conditions such as severe disorders of AA utilisation or in inborn errors of AA metabolism. An AA intake of 0.8 g/kg/day is generally recommended for adult patients with a normal metabolism, which may be increased to 1.2–1.5 g/kg/day, or to 2.0 or 2.5 g/kg/day in exceptional cases. Sufficient non-nitrogen energy sources should be added in order to assure adequate utilisation of AA. A nitrogen calorie ratio of 1:130 to 1:170 (g N/kcal) or 1:21 to 1:27 (g AA/kcal) is recommended under normal metabolic conditions. In critically ill patients glutamine should be administered parenterally if indicated in the form of peptides, for example 0.3–0.4 g glutamine dipeptide/kg body weight/day (=0.2–0.26 g glutamine/kg body weight/day). No recommendation can be made for glutamine supplementation in PN for patients with acute pancreatitis or after bone marrow transplantation (BMT), and in newborns. The application of arginine is currently not warranted as a supplement in PN in adults. N-acetyl AA are only of limited use as alternative AA sources. There is currently no indication for use of AA solutions with an increased content of glycine, branched-chain AAs (BCAA) and ornithine-α-ketoglutarate (OKG) in all patients receiving PN. AA solutions with an increased proportion of BCAA are recommended in the treatment of hepatic encephalopathy (III–IV).
There are special challenges in implementing parenteral nutrition (PN) in paediatric patients, which arises from the wide range of patients, ranging from extremely premature infants up to teenagers weighing up to and over 100 kg, and their varying substrate requirements. Age and maturity-related changes of the metabolism and fluid and nutrient requirements must be taken into consideration along with the clinical situation during which PN is applied. The indication, the procedure as well as the intake of fluid and substrates are very different to that known in PN-practice in adult patients, e.g. the fluid, nutrient and energy needs of premature infants and newborns per kg body weight are markedly higher than of older paediatric and adult patients. Premature infants <35 weeks of pregnancy and most sick term infants usually require full or partial PN. In neonates the actual amount of PN administered must be calculated (not estimated). Enteral nutrition should be gradually introduced and should replace PN as quickly as possible in order to minimise any side-effects from exposure to PN. Inadequate substrate intake in early infancy can cause long-term detrimental effects in terms of metabolic programming of the risk of illness in later life. If energy and nutrient demands in children and adolescents cannot be met through enteral nutrition, partial or total PN should be considered within 7 days or less depending on the nutritional state and clinical conditions.
Background: A growing number of German hospitals have been privatized with the intention of increasing cost effectiveness and improving the quality of health care. Numerous studies investigated what possible qualitative and economic consequences these changes issues might have on patient care. However, little is known about how this privatization trend relates to physicians' working conditions and job satisfaction. It was anticipated that different working conditions would be associated with different types of hospital ownership. To that end, this study's purpose is to compare how physicians, working for both public and privatized hospitals, rate their respective psychosocial working conditions and job satisfaction.
Methods: The study was designed as a cross-sectional comparison using questionnaire data from 203 physicians working at German hospitals of different ownership types (private for-profit, public and private nonprofit).
Results: The present study shows that several aspects of physicians' perceived working conditions differ significantly depending on hospital ownership. However, results also indicated that physicians' job satisfaction does not vary between different types of hospital ownership. Finally, it was demonstrated that job demands and resources are associated with job satisfaction, while type of ownership is not.
Conclusion: This study represents one of a few studies that investigate the effect of hospital ownership on physicians work situation and demonstrated that the type of ownership is a potential factor accounting for differences in working conditions. The findings provide an informative basis to find solutions improving physicians' work at German hospitals.
* Cooperation between "jeder-fehlerzaehlt.de" and the Techniker statutory insurance company
* "PRIoritising multiple medication in multi-morbid patients" – PRIMUM-Pilot study gets off to successful start
* New work area: Quality promotion and concept development
* Frankfurt Training Program in Evidence-Based Medicine
* Another change in our institute is the new arrival of Sabine Pommeresch
* 2nd General Practice Day in Frankfurt
kurz und kn@pp news : Nr. 17
(2009)
kurz und kn@pp news : Nr. 16
(2009)
* Kooperation von "jeder-Fehler-zaehlt.de" mit der Techniker Krankenkasse
* "PRIorisierung von MUltimedikation bei Multimorbidität" – PRIMUM-Pilotstudie erfolgreich gestartet
* Neuer Arbeitsbereich: Qualitätsförderung und Konzeptentwicklung
* Neu im Institut ist Sabine Pommeresch
* Frankfurter Fortbildungsreihe Evidenzbasierte Medizin
* 2. Frankfurter Tag der Allgemeinmedizin: Jetzt online
kurz und kn@pp news : Nr. 15
(2009)
Following the discovery of context-dependent synchronization of oscillatory neuronal responses in the visual system, the role of neural synchrony in cortical networks has been expanded to provide a general mechanism for the coordination of distributed neural activity patterns. In the current paper, we present an update of the status of this hypothesis through summarizing recent results from our laboratory that suggest important new insights regarding the mechanisms, function and relevance of this phenomenon. In the first part, we present recent results derived from animal experiments and mathematical simulations that provide novel explanations and mechanisms for zero and nero-zero phase lag synchronization. In the second part, we shall discuss the role of neural synchrony for expectancy during perceptual organization and its role in conscious experience. This will be followed by evidence that indicates that in addition to supporting conscious cognition, neural synchrony is abnormal in major brain disorders, such as schizophrenia and autism spectrum disorders. We conclude this paper with suggestions for further research as well as with critical issues that need to be addressed in future studies.